April 1, 2021
Germany has reported 31 cases of blood clots in the brain from AstraZeneca COVID-19 vaccine. The cases are associated with CSVT or sinus vein thrombosis as per the German regulator and 19 out of 31 cases are linked to thrombocytopenia or blood platelet deficiency.
Use of AstraZeneca covid-19 vaccine has already been suspended in many European countries due to its adverse side effects. German vaccine regulator also reported 31 cases of blood disorder after AstraZeneca jab in Germany.
The Paul Ehrlich Institute (Vaccine regulator of Germany) said it has recorded 31 cases of a rare blood clot in the brain after people were vaccinated against COVID-19 with an AstraZeneca jab. Nine of these cases have resulted in deaths, the PEI added.
The German registered cases are associated with CSVT or sinus vein thrombosis as per PEI. 19 out of 31 cases are linked to thrombocytopenia or blood platelet deficiency.
Two of Berlin’s state hospital groups (Vivantes and Charite ) have also suspended administering this jab to women under the age of 55 in a separate development.
GreatGameIndia is a journal on geopolitics and international relations, providing global intelligence through strategic analysis by placing events in a geopolitical and historical framework to better understand international developments and the world around us.
Contributors to GreatGame India inclue physicists, computer professionals, management experts, business analysts, geopolitical strategists and others, who from their backgrounds, developed a systematic research methodology and study process to understand and unearth the time hidden documented historical events and enhance everybody’s understanding.